BOBBIE HUNTER: Open Payments
NPI 1427286269 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 20 payments from 14 companies in 2025. Trend: 2023 $1,184 · 2024 $1,439 · 2025 $2,106
Food & beverage: $2,106
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $329 |
| Abbott Laboratories | 2 | $285 |
| ABBVIE INC. | 2 | $214 |
| Gilead Sciences, Inc. | 2 | $204 |
| Vanda Pharmaceuticals Inc. | 2 | $183 |
| Ardelyx, Inc. | 1 | $126 |
| Alkermes, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Novo Nordisk Inc | 1 | $124 |
Products named: FREESTYLE LIBRE 3, VRAYLAR, AIRSUPRA, FANAPT, Biktarvy, IBSRELA, LYBALVI, BREZTRI.
Industry payments across GA — which companies pay providers there.
